Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
2000 2
2001 1
2002 3
2003 4
2004 5
2005 9
2006 9
2007 10
2008 8
2009 8
2010 11
2011 13
2012 13
2013 25
2014 26
2015 17
2016 16
2017 27
2018 30
2019 23
2020 16
2021 10
2022 15
2023 34
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for lisa race
Search for Lisa Racie instead (2 results)
Reducing Racial Inequities in Health: Using What We Already Know to Take Action.
Williams DR, Cooper LA. Williams DR, et al. Int J Environ Res Public Health. 2019 Feb 19;16(4):606. doi: 10.3390/ijerph16040606. Int J Environ Res Public Health. 2019. PMID: 30791452 Free PMC article. Review.
This paper provides an overview of the scientific evidence pointing to critically needed steps to reduce racial inequities in health. First, it argues that communities of opportunity should be developed to minimize some of the adverse impacts of systemic racism. ...This wi …
This paper provides an overview of the scientific evidence pointing to critically needed steps to reduce racial inequities in health. …
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC. Carey LA, et al. JAMA. 2006 Jun 7;295(21):2492-502. doi: 10.1001/jama.295.21.2492. JAMA. 2006. PMID: 16757721
MAIN OUTCOME MEASURES: We examined the prevalence of breast cancer subtypes within racial and menopausal subsets and determined their associations with tumor size, axillary nodal status, mitotic index, nuclear pleomorphism, combined grade, p53 mutation status, and breast c …
MAIN OUTCOME MEASURES: We examined the prevalence of breast cancer subtypes within racial and menopausal subsets and determined their …
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group. El Sahly HM, et al. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22. N Engl J Med. 2021. PMID: 34551225 Free PMC article. Clinical Trial.
The efficacy in preventing severe disease was 98.2% (95% CI, 92.8 to 99.6), with 2 cases in the mRNA-1273 group and 106 in the placebo group, and the efficacy in preventing asymptomatic infection starting 14 days after the second injection was 63.0% (95% CI, 56.6 to 68.5), with 2 …
The efficacy in preventing severe disease was 98.2% (95% CI, 92.8 to 99.6), with 2 cases in the mRNA-1273 group and 106 in the placebo group …
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016.
Tomás CC, Oliveira E, Sousa D, Uba-Chupel M, Furtado G, Rocha C, Teixeira A, Ferreira P, Alves C, Gisin S, Catarino E, Carvalho N, Coucelo T, Bonfim L, Silva C, Franco D, González JA, Jardim HG, Silva R, Baixinho CL, Presado MªH, Marques MªF, Cardoso ME, Cunha M, Mendes J, Xavier A, Galhardo A, Couto M, Frade JG, Nunes C, Mesquita JR, Nascimento MS, Gonçalves G, Castro C, Mártires A, Monteiro MªJ, Rainho C, Caballero FP, Monago FM, Guerrero JT, Monago RM, Trigo AP, Gutierrez ML, Milanés GM, Reina MG, Villanueva AG, Piñero AS, Aliseda IR, Ramirez FB, Ribeiro A, Quelhas A, Manso C, Caballero FP, Guerrero JT, Monago FM, Santos RB, Jimenez NR, Nuñez CG, Gomez IR, Fernandez MªJL, Marquez LA, Moreno AL, Huertas MªJT, Ramirez FB, Seabra D, Salvador MªC, Braga L, Parreira P, Salgueiro-Oliveira A, Arreguy-Sena C, Oliveira BF, Henriques MªA, Santos J, Lebre S, Marques A, Festas C, Rodrigues S, Ribeiro A, Lumini J, Figueiredo AG, Hernandez-Martinez FJ, Campi L, Quintana-Montesdeoca MªP, Jimenez-Diaz JF, Rodriguez-De-Vera BC, Parente A, Mata MªA, Pereira AMª, Fernandes A, Brás M, Pinto MªR, Parreira P, Basto ML, Rei AC, Mónico LM, Sousa G, Morna C, Freitas O, Freitas G, Jardim A, Vasconcelos … See abstract for full author list ➔ Tomás CC, et al. BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200. doi: 10.1186/s12913-016-1423-5. BMC Health Serv Res. 2016. PMID: 27409075 Free PMC article.
Ferreira, Alexandre Rodrigues, Margarida Ferreira, Isabel Oliveira P38 Study of graduate's satisfaction with the school of nursing Manuela Ferreira, Jessica Neves, Diana Costa, Soraia Duarte, Joana Silva, Bruno Santos P39 Partnership between the school of nursing and the hospital …
Ferreira, Alexandre Rodrigues, Margarida Ferreira, Isabel Oliveira P38 Study of graduate's satisfaction with the school of nursing Manuela F …
Hope across cultural groups.
Edwards LM, McConnell K. Edwards LM, et al. Curr Opin Psychol. 2023 Feb;49:101505. doi: 10.1016/j.copsyc.2022.101505. Epub 2022 Nov 1. Curr Opin Psychol. 2023. PMID: 36473375 Review.
While early studies focused on looking at differences in hope between racial groups, recent research has focused more broadly on the measurement of hope and how hope operates in diverse contexts and nations. Many translations of the adult and child versions of the h …
While early studies focused on looking at differences in hope between racial groups, recent research has focused more broadly …
Race/ethnicity matching boosts enrollment of black participants in clinical trials.
Segre LS, Davila RC, Carter C, Arndt S. Segre LS, et al. Contemp Clin Trials. 2022 Nov;122:106936. doi: 10.1016/j.cct.2022.106936. Epub 2022 Sep 23. Contemp Clin Trials. 2022. PMID: 36162741
One proposed solution is race/ethnicity matching (i.e., aligning the racial or ethnic identity of the trial recruiter with that of the desired participant), but in practice this idea has yielded mixed results. ...CONCLUSIONS: The key finding is that the Black recrui …
One proposed solution is race/ethnicity matching (i.e., aligning the racial or ethnic identity of the trial recruiter with tha …
Biogeographical ancestry and race.
Gannett L. Gannett L. Stud Hist Philos Biol Biomed Sci. 2014 Sep;47 Pt A:173-84. doi: 10.1016/j.shpsc.2014.05.017. Epub 2014 Jun 29. Stud Hist Philos Biol Biomed Sci. 2014. PMID: 24989973
The use of racial and ethnic categories in biological and biomedical research is controversial-for example, in the comparison of disease risk in different groups or as a means of making use of or controlling for population structure in the mapping of genes to chromo …
The use of racial and ethnic categories in biological and biomedical research is controversial-for example, in the comparison of dise …
Analysis of Pregnancy Complications and Epigenetic Gestational Age of Newborns.
Ladd-Acosta C, Vang E, Barrett ES, Bulka CM, Bush NR, Cardenas A, Dabelea D, Dunlop AL, Fry RC, Gao X, Goodrich JM, Herbstman J, Hivert MF, Kahn LG, Karagas MR, Kennedy EM, Knight AK, Mohazzab-Hosseinian S, Morin A, Niu Z, O'Shea TM, Palmore M, Ruden D, Schmidt RJ, Smith AK, Song A, Spindel ER, Trasande L, Volk H, Weisenberger DJ, Breton CV; Environmental Influences on Child Health Outcomes Program. Ladd-Acosta C, et al. JAMA Netw Open. 2023 Feb 1;6(2):e230672. doi: 10.1001/jamanetworkopen.2023.0672. JAMA Netw Open. 2023. PMID: 36826815 Free PMC article.
Reported races included Asian (49 participants [2.7%]), Black (390 participants [21.7%]), White (1026 participants [57.0%]), and other races (92 participants [5.1%]) (ie, American Indian or Alaska Native, Native Hawaiian or other Pacific Islander, multiple races, and other rac …
Reported races included Asian (49 participants [2.7%]), Black (390 participants [21.7%]), White (1026 participants [57.0%]), and other races …
Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines.
Kenigsberg TA, Goddard K, Hanson KE, Lewis N, Klein N, Irving SA, Naleway AL, Crane B, Kauffman TL, Xu S, Daley MF, Hurley LP, Kaiser R, Jackson LA, Jazwa A, Weintraub ES. Kenigsberg TA, et al. Vaccine. 2023 Sep 7;41(39):5678-5682. doi: 10.1016/j.vaccine.2023.08.023. Epub 2023 Aug 19. Vaccine. 2023. PMID: 37599140
We describe simultaneous influenza and mRNA COVID-19 bivalent booster vaccine administration between August 31-December 31, 2022, among persons aged 6 months in the Vaccine Safety Datalink (VSD) by COVID-19 bivalent booster vaccine type, influenza vaccine type, age group, sex, an …
We describe simultaneous influenza and mRNA COVID-19 bivalent booster vaccine administration between August 31-December 31, 2022, among pers …
305 results